Finerenone Investor-Webinar November 2021

During the Pharma-Investor-Webinar on November 15, 2021 with Christian Rommel, Head of R&D at Pharma and Sebastian Guth, Head of Commercial Operations Americas at Pharma we provided insights regarding the clinical relevance of outcomes with Finerenone (Kerendia™) and showcased how Finerenone addresses high unmet needs in kidney and cardiovascular diseases. The presentation was followed by a Q&A session.

Monday, November 15, 2021